ES518758A0 - Un procedimiento para preparar azetidinas. - Google Patents

Un procedimiento para preparar azetidinas.

Info

Publication number
ES518758A0
ES518758A0 ES518758A ES518758A ES518758A0 ES 518758 A0 ES518758 A0 ES 518758A0 ES 518758 A ES518758 A ES 518758A ES 518758 A ES518758 A ES 518758A ES 518758 A0 ES518758 A0 ES 518758A0
Authority
ES
Spain
Prior art keywords
azetidins
preparing
procedure
preparing azetidins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES518758A
Other languages
English (en)
Other versions
ES8403108A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of ES8403108A1 publication Critical patent/ES8403108A1/es
Publication of ES518758A0 publication Critical patent/ES518758A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ES518758A 1982-01-04 1983-01-03 Un procedimiento para preparar azetidinas. Granted ES518758A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33653782A 1982-01-04 1982-01-04
US36860982A 1982-04-15 1982-04-15

Publications (2)

Publication Number Publication Date
ES8403108A1 ES8403108A1 (es) 1984-03-01
ES518758A0 true ES518758A0 (es) 1984-03-01

Family

ID=26990250

Family Applications (1)

Application Number Title Priority Date Filing Date
ES518758A Granted ES518758A0 (es) 1982-01-04 1983-01-03 Un procedimiento para preparar azetidinas.

Country Status (19)

Country Link
EP (1) EP0085291B1 (es)
JP (1) JPS58121269A (es)
KR (1) KR890000418B1 (es)
AU (1) AU570912B2 (es)
CA (1) CA1272726C (es)
DD (1) DD207907A5 (es)
DE (1) DE3377712D1 (es)
DK (1) DK583A (es)
ES (1) ES518758A0 (es)
FI (1) FI830017L (es)
GR (1) GR77135B (es)
HU (1) HU188986B (es)
IE (1) IE54388B1 (es)
IL (1) IL67528A (es)
NO (1) NO830003L (es)
NZ (1) NZ202891A (es)
PH (1) PH21695A (es)
PT (1) PT76064A (es)
SU (1) SU1391496A3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
EP0246786A1 (en) * 1986-05-23 1987-11-25 The Upjohn Company N-1 subsituted sulfonylaminocarbonyl, C-4 substituted monobactams
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
EP0357604A1 (en) * 1987-02-27 1990-03-14 The Upjohn Company Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0344707A3 (en) * 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines

Also Published As

Publication number Publication date
DE3377712D1 (de) 1988-09-22
NO830003L (no) 1983-07-05
IL67528A (en) 1986-04-29
PT76064A (en) 1983-02-01
ES8403108A1 (es) 1984-03-01
DD207907A5 (de) 1984-03-21
CA1272726C (en) 1990-08-14
HU188986B (en) 1986-05-28
EP0085291B1 (en) 1988-08-17
DK583A (da) 1983-07-05
KR840002808A (ko) 1984-07-21
EP0085291A1 (en) 1983-08-10
DK583D0 (da) 1983-01-03
CA1260472A (en) 1989-09-26
SU1391496A3 (ru) 1988-04-23
JPS58121269A (ja) 1983-07-19
AU9161782A (en) 1983-07-14
NZ202891A (en) 1986-02-21
KR890000418B1 (ko) 1989-03-17
GR77135B (es) 1984-09-07
AU570912B2 (en) 1988-03-31
IE823087L (en) 1983-07-04
PH21695A (en) 1988-01-13
IE54388B1 (en) 1989-09-13
FI830017A0 (fi) 1983-01-04
FI830017L (fi) 1983-07-05

Similar Documents

Publication Publication Date Title
ES521370A0 (es) Un procedimiento para obtener un polidoma.
ES500726A0 (es) Un procedimiento para preparar diaminopiridinas
ES534202A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES500727A0 (es) Un procedimiento para preparar imidazo-piridinas
ES523064A0 (es) Procedimiento para preparar azetidinas.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES520364A0 (es) Un procedimiento para preparar compuestos de cefem.
ES530392A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES538192A0 (es) Un procedimiento para preparar un 2-bromo-6b-9a - difluoro-11b, 17a, 21-trihidroxi-1, 4-pregnadien-3, 20-diona-17, 21-diester
ES521813A0 (es) Procedimiento para preparar alcohil-polisacaridos.
ES520531A0 (es) Procedimiento para preparar tioeteres.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES523277A0 (es) Un procedimiento para preparar peptidos.
ES527278A0 (es) Un procedimiento para obtener 2,5-anhidro-3,4,6-tri-o-acil-d-alonselenocarboxamida
ES500464A0 (es) Un procedimiento para preparar 2-halogeno-acetanilidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401